<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Fukuyama <z:hpo ids='HP_0003741'>congenital muscular dystrophy</z:hpo> (FCMD) is a unique autosomal recessively inherited condition which is characterized by a combination of systemic progressive <z:hpo ids='HP_0003560'>muscular dystrophy</z:hpo> (PMD), severe cerebrocerebellar cortical malformation in association with/without <z:chebi fb="46" ids="15035">retinal</z:chebi> derrangement of very early <z:hpo ids='HP_0003674'>onset</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>FCMD is the second most prevalent type of PMD in Japan, while it is extremely rare outside Japan </plain></SENT>
<SENT sid="2" pm="."><plain>Historically, the first half of the 20th century was a dark age in terms of CMD </plain></SENT>
<SENT sid="3" pm="."><plain>The entity of CMD was practically absent in the international classification of PMD until 1986, when MIM first enlisted FCMD as a disease entity </plain></SENT>
<SENT sid="4" pm="."><plain>In the midst of this dark age, that is, in 1960, we first reported a series of 15 cases of CMD and advocated that this will represent a completely new disease entity </plain></SENT>
<SENT sid="5" pm="."><plain>To reach a correct diagnosis, a key role was played by keen clinical observation, application of newly explored diagnostic procedures, including muscle biopsy, needle electromyography and determination of serum <z:chebi fb="2" ids="16919">creatine</z:chebi> kinase activities </plain></SENT>
<SENT sid="6" pm="."><plain>Another important factor was an exhaustive review of pertinent literature </plain></SENT>
<SENT sid="7" pm="."><plain>Through exercising the above approaches in combination, we could reach to our conviction that we are dealing with a entirely new type of CMD </plain></SENT>
</text></document>